By: UI Health Care Marketing and Communications | 2016.05.05 | 09:50 am
Ryan Boudreau, UI assistant professor of internal medicine, has received a three-year, $438,657 Young Investigator award from the Roy J. Carver Charitable Trust to investigate regulatory mechanisms that control when and where proteins are made within heart cells.
External Media | 2015.03.23 | 12:15 pm
A new study from lead investigator Jennifer Robinson, an epidemiologist in the College of Public Health, shows that a cholesterol drug may also be able to reduce heart attacks and strokes.
Center renamed the Francois M. Abboud Cardiovascular Research Center
By: Tom Moore | 2013.12.04 | 01:46 pm
The Board of Regents, State of Iowa, today (Wednesday, Dec. 4) approved a request from the University of Iowa to re-name the UI Cardiovascular Research Center in honor of its founder, Francois Abboud, M.D.
New technique from UI study uses finger's pulse to measure stiffness in the aorta
By: Jennifer Patterson | 2013.09.04 | 08:00 am
A University of Iowa physiologist has a new technique to measure the stiffness of the aorta, a common risk factor for heart disease. The procedure involves measuring the pulse in the finger or on the arm, combined with an individual's age and body mass index. Results are published in the "American Journal of Physiology Heart and Circulatory Physiology."
University of Iowa team finds enzyme in airway lining cells could hold key for asthma sufferers
By: Richard C. Lewis | 2013.07.24 | 01:03 pm
A University of Iowa-led team has found a promising, new way to treat asthma: Target an enzyme in airway lining cells. The finding could lead to the development of drugs that block the enzyme, CaMKII, from excessive oxidation, which can trigger asthma attacks.
Targeting pathway may lead to better hypertension treatments for at-risk patients
By: Jennifer Brown | 2013.04.11 | 11:02 am
A University of Iowa study identifies a brain protein that acts as a communications hub for blood pressure control, and links cardiovascular disease and obesity to hypertension.
Overactive enzyme may be factor
By: Jennifer Brown | 2013.02.15 | 11:40 am
Having diabetes doubles a person’s risk of dying after a heart attack, but the reason for the increased risk is not clear. A new University of Iowa study suggests the link may lie in the over-activation of an important heart enzyme, which leads to death of pacemaker cells in the heart, abnormal heart rhythm, and increased risk of sudden death in diabetic mice following a heart attack.
By: UI Health Care Marketing and Communications | 2012.10.31 | 09:58 am
Adults age 45 and older with elevated triglycerides who have had a stroke, heart attack, chest pain, or heart surgery are invited to participate in a University of Iowa research study on preventing these conditions.
Inhibiting CaMKII activity could lead to new heart disease therapies
By: Jennifer Brown | 2012.10.11 | 02:51 pm
A University of Iowa study shows that CaM kinase II enzyme triggers heart cell death by making the cells’ energy-producing mitochondria leaky. Inhibiting the enzyme in mitochondria protected mice from heart cell death during heart attack and other forms of heart stress. The findings could lead to better therapies for common forms of heart disease.